Results 181 to 190 of about 7,556,071 (335)

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

open access: yesMolecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo   +8 more
wiley   +1 more source

Functional outcome of unstable pelvic fractures treated in a level III hospital in a developing country: a 10-year prospective observational study. [PDF]

open access: yesJ Orthop Surg Res, 2022
Nana CT   +7 more
europepmc   +1 more source

Plasma Protein C and Antithrombin III Levels in Polycythemic Newborns [PDF]

open access: bronze, 1989
Kadriye Yurdakök   +4 more
openalex   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine   +10 more
wiley   +1 more source

Prognostic Value of Anti-Thrombin III Level in Neonatal Sepsis

open access: yesJournal of Rawalpindi Medical College, 2016
Background: To determine levels of Antithrombin III and its prognostic value in predicting neonatal sepsis. Methods: In this descriptive study full term neonates (n=70)were recruited.
Sidra Tul Muntaha
doaj  

A Kinetic Approach To The Definition Of Pathophysiology Of Low Antithrombin III (AT) Levels In Patients [PDF]

open access: bronze, 1981
E. B. Reeve   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy